When a melanoma cell lysate was used to load DCs with tumor antigens together with poly(I:C), ExVs were generated, capable of inducing activation of melanoma-specific CD8+T cells and recruiting cytotoxic CD8+T cells, NK and NK-T cells to the tumor site, resulting in significantly reduced tumor growth and enhanced survival. The gene discussed is CD8A; the disease is melanoma.